
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Oncology Today with Dr Neil Love
00:00
Addressing cardiac dysfunction and HER2 therapies
Panel (Zev, Haley) weigh risks of HER2 agents in reduced ejection fraction and emphasize monitoring.
Play episode from 03:07
Transcript


